Your search returned 2195 results.

Results
	1.	Does the Benefit of Cholesterol-Lowering of a Given Magnitude Depend on the Drug Intervention Used? [electronic resource] by Streja, Elani Streja, Dan Producer: 20200417 In: Circulation. Cardiovascular quality and outcomes vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older. [electronic resource] by Li, Daniel McCaw, Zachary R Wei, Lee-Jen Producer: 20201221 In: JAMA cardiology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older. [electronic resource] by Weingärtner, Oliver Sijbrands, Eric J G Lütjohann, Dieter Producer: 20201221 In: JAMA cardiology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older-Reply. [electronic resource] by Bach, Richard G Cannon, Christopher P Blazing, Michael A Producer: 20201221 In: JAMA cardiology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Letter by Koh Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)". [electronic resource] by Koh, Kwang Kon Producer: 20190924 In: Circulation vol. 138 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Letter by Donzelli et al Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)". [electronic resource] by Donzelli, Alberto Schivalocchi, Alessandro Giudicatti, Giulia Producer: 20190924 In: Circulation vol. 138 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Ezetimibe: Likely to Be Beneficial For All. [electronic resource] by Herrington, William G Preiss, David Armitage, Jane Producer: 20190429 In: Circulation vol. 137 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Letter by Cordero et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)". [electronic resource] by Cordero, Alberto Bertomeu-González, Vicente Rodriguez-Mañero, Moises Producer: 20190802 In: Circulation vol. 137 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Letter by Koh Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)". [electronic resource] by Koh, Kwang Kon Producer: 20190802 In: Circulation vol. 137 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Letter by Del Pinto et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)". [electronic resource] by Del Pinto, Rita Ferri, Claudio Borghi, Claudio Producer: 20190802 In: Circulation vol. 137 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Letter by Thomopoulos and Michalopoulou Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)". [electronic resource] by Thomopoulos, Costas Michalopoulou, Helena Producer: 20190802 In: Circulation vol. 137 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)". [electronic resource] by Bohula, Erin A Wiviott, Stephen D Giugliano, Robert P Park, Jeong-Gun Murphy, Sabina A Cannon, Christopher P Braunwald, Eugene Producer: 20190802 In: Circulation vol. 137 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	The good side of cholesterol: a requirement for maintenance of intestinal integrity. [electronic resource] by Hui, David Y Producer: 20190121 In: Journal of lipid research vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Physicochemical characterization of atorvastatin calcium/ezetimibe amorphous nano-solid dispersions prepared by electrospraying method. [electronic resource] by Jahangiri, Azin Barzegar-Jalali, Mohammad Javadzadeh, Yousef Hamishehkar, Hamed Adibkia, Khosro Producer: 20180124 In: Artificial cells, nanomedicine, and biotechnology vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	On call. I don't understand the problem with Vytorin. The two components when used separately work fine, but when mixed together things change. Why? [electronic resource] by Simon, Harvey B Producer: 20081202 In: Harvard men's health watch vol. 13 Availability: No items available. Save to lists Add to cart (remove)
	16.	A closer look at an ezetimibe discussion. [electronic resource] by Crump, Bill Producer: 20190828 In: The Journal of family practice vol. 67 Availability: No items available. Save to lists Add to cart (remove)
	17.	Rx for uncertainty. Does a popular cholesterol-lowering drug do what it's supposed to do? [electronic resource] by Law, Bridget Murray Producer: 20080603 In: Diabetes forecast vol. 61 Availability: No items available. Save to lists Add to cart (remove)
	18.	Ezetimibe, Risk Stratification, and Secondary Prevention. [electronic resource] by DuBroff, Robert J Producer: 20190523 In: Journal of the American College of Cardiology vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	[Development of the "Consensus guidelines for the use of drugs in renal failure"]. [electronic resource] by March Pujol, Maria Antonia Vía Sosa, Maria Àngels Travé Mercadé, Pere Martínez-Castelao, Alberto Producer: 20190527 In: Atencion primaria vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Reply: Ezetimibe, Risk Stratification, and Secondary Prevention. [electronic resource] by Bohula, Erin A Morrow, David A Giugliano, Robert P Cannon, Christopher P Braunwald, Eugene Producer: 20190523 In: Journal of the American College of Cardiology vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 2195 results.